Course of gut inflammation in spondylarthropathies and therapeutic consequences

Altomente, 1994, Clinical silent inflammatory gut lesions in undifferentiated spondyloarthropathies, Clinical Rheumatology, 13, 565, 10.1007/BF02242995 Amor, 1979, Reiter's syndrome: long-term follow-up data, Annals of the Rheumatic Diseases, 38, 32, 10.1136/ard.38.Suppl_1.32 Azad Khan, 1977, An experiment to determine the active therapeutic moiety of Sulphasalazine, Lancet, ii, 892, 10.1016/S0140-6736(77)90831-5 Banares, 1995, Bowel inflammation in anterior uveitis and spondyloarthropathy, Journal of Rheumatology, 22, 1112 Bjarnason, 1988, Treatment of NSAID-induced intestinal inflammation, Gut, 29, 1434 Bremell, 1991, Rheumatic symptoms following an outbreak of Campylobacter enteritis: a five year follow-up, Annals of the Rheumatic Diseases, 30, 934, 10.1136/ard.50.12.934 Carette, 1983, The natural disease course of ankylosing spondylitis, Arthritis and Rheumatism, 26, 186, 10.1002/art.1780260210 Cuvelier, 1987, Histopathology of intestinal inflammation related to reactive arthritis, Gut, 28, 394, 10.1136/gut.28.4.394 Dick, 1964, Controlled trial of Sulphasalazine in the treatment of ulcerative colitis, Gut, 5, 437, 10.1136/gut.5.5.437 Dissanayake, 1973, A controlled trial of long-term maintenance treatment of ulcerative colitis with Sulphasalazine, Gut, 14, 923, 10.1136/gut.14.12.923 Dougados, 1986, Sulphasalazine in ankylosing spondylitis: a double-blind controlled study in 60 patients, British Journal of Rheumatology, 293, 911 Dougados, 1987, Iléocolonoscopie systhématique au cours des spondylarthropathies séronégatives, Revue du Rhumatisme, 54, 279 Dougados, 1995, Sulphasalazine in spondylarthropathies: a randomized multicenter, double-blind, placebo-controlled study, Arthritis and Rheumatism, 38, 618, 10.1002/art.1780380507 Eastmond, 1982, A sequential study of the relationship between faecal Klebsiella aerogenus and the common clinical manifestations of ankylosing spondylitis, Annals of the Rheumatic Diseases, 41, 15, 10.1136/ard.41.1.15 Ebringer, 1978, Sequential studies in ankylosing spondylitis. Association of Klebsiella pneumoniae with active disease, Annals of the Rheumatic Diseases, 37, 146, 10.1136/ard.37.2.146 Feltelius, 1986, Sulphasalazine in ankylosing spondylitis, Annals of the Rheumatic Diseases, 45, 396, 10.1136/ard.45.5.396 Ferraz, 1990, Meta-analysis of Sulphasalazine in ankylosing spondylitis, Journal of Rheumatology, 17, 1482 Fox, 1979, The chronicity of symptoms and disability in Reiter's syndrome, Annals of Internal Medicine, 91, 190, 10.7326/0003-4819-91-2-190 Fraser, 1990, Evaluation of sulphasalazine in ankylosing spondylitis—an interventional study, British Journal of Rheumatology, 29, 37, 10.1093/rheumatology/29.1.37 Fraser, 1993, Sulphasalazine in the management of psoriatic arthritis, British Journal of Rheumatology, 32, 923, 10.1093/rheumatology/32.10.923 Gedalia, 1993, Sulphasalazine in the treatment of pauciarticular onset juvenile chronic arthritis, Clinical Rheumatology, 12, 511, 10.1007/BF02231781 Granfors, 1986, IgA anti-Yersinia antibodies in Yersinia triggered reactive arthritis, Annals of the Rheumatic Diseases, 45, 561, 10.1136/ard.45.7.561 Granfors, 1989, Yersinia antigens in synovial fluid cells from patients with reactive arthritis, New England Journal of Medicine, 320, 216, 10.1056/NEJM198901263200404 Hammer, 1990, Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders, Cell, 63, 109, 10.1016/0092-8674(90)90512-D Haslock, 1973, Arthritis and Crohn's disease, Annals of the Rheumatic Diseases, 32, 479, 10.1136/ard.32.6.479 Herrlinger, 1992, Long term prognosis in Yersinia arthritis: clinical and serological findings, Annals of the Rheumatic Diseases, 51, 1332, 10.1136/ard.51.12.1332 Joos, 1991, Sulphasalazine treatment in juvenile chronic arthritis: an open study, Journal of Rheumatology, 18, 880 Keat, 1983, Reiter's syndrome and reactive arthritis in perspective, New England Journal of Medicine, 309, 1606, 10.1056/NEJM198312293092604 Kennedy, 1993, The natural history of ankylosing spondylitis. Does it burn out?, Journal of Rheumatology, 20, 688 Khan, 1977, Comparison of clinical features in HLA-B27-positive and negative patients with ankylosing spondylitis, Arthritis and Rheumatism, 20, 909, 10.1002/art.1780200401 Khan, 1980, Genetic heterogeneity in primary ankylosing spondylitis, Journal of Rheumatology, 7, 383 Kirwan, 1993, The course of established ankylosing spondylitis and the effects of sulphasalazine over 3 years, British Journal of Rheumatology, 32, 729, 10.1093/rheumatology/32.8.729 De Koning, 1989, Yersinia in intestinal biopsy specimens from patients with seronegative spondylarthropathies: correlation with specific serum IgA antibodies, Journal of Infectious Diseases, 159, 109, 10.1093/infdis/159.1.109 Leirisalo-Repo, 1988, Ten-year follow-up study of patients with yersinia arthritis, Arthritis and Rheumatism, 31, 533, 10.1002/art.1780310410 Leirisalo-Repo, 1982, Follow-up study on patients with Reiter's disease and reactive arthritis with special reference to HLA-B27, Arthritis and Rheumatism, 25, 249, 10.1002/art.1780250302 Leirisalo-Repo, 1994, High frequency of silent inflammatory bowel disease in spondylarthropathy, Arthritis and Rheumatism, 37, 23, 10.1002/art.1780370105 Lindholm, 1991, Late complications after a Yersinia enterocolitica epidemic: a follow-up study, Annals of the Rheumatic Diseases, 50, 694, 10.1136/ard.50.10.694 Linssen, 1988, B27-positive diseases versus B27-negative diseases, Annals of the Rheumatic Diseases, 47, 431, 10.1136/ard.47.5.431 Malchow, 1984, European Cooperative Disease Study (ECDS): results of drug treatment, Gastroenterology, 86, 249, 10.1016/0016-5085(84)90409-8 Martinez-Gonzalez, 1994, Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives, British Journal of Rheumatology, 33, 644, 10.1093/rheumatology/33.7.644 Mau, 1988, Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year follow-up, Journal of Rheumatology, 15, 1109 Mayberry, 1989, Epidemiological study of asymptomatic inflammatory bowel disease: the identification of cases during a screening programme for colorectal cancer, Gut, 30, 481, 10.1136/gut.30.4.481 Meuwissen, 1978, Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis, Annals of the Rheumatic Diseases, 37, 30, 10.1136/ard.37.1.30 Mielants, 1985, HLA-B27 related arthritis and bowel inflammation. Part 1. Sulfasalazine (Salazopyrin) in HLA-B27 related reactive arthritis, Journal of Rheumatology, 12, 287 Mielants, 1990, The gut in the spondylarthropathies, Journal of Rheumatology, 17, 7 Mielants, 1986, Sulphasalazine (Salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis, Clinical Rheumatology, 5, 80, 10.1007/BF02030973 Mielants, 1987, Gut inflammation in the pathogenesis of idiopathic forms of reactive arthritis and in the peripheral joint involvement of ankylosing spondylitis, 11 Mielants, 1987, Repeat ileocolonoscopy in reactive arthritis, Journal of Rheumatology, 14, 456 Mielants, 1987, Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation, Journal of Rheumatology, 14, 459 Mielants, 1987, HLA-antigens in seronegative spondylarthropathies, reactive arthritis and arthritis in ankylosing spondylitis: relation to gut inflammation, Journal of Rheumatology, 14, 466 Mielants, 1988, Ileocolonoscopic findings in seronegative spondylarthropathies, British Journal of Rheumatology, 27, 95, 10.1093/rheumatology/XXVII.suppl_2.95 Mielants, 1989, Subclinical involvement of the gut in undifferentiated spondylarthropathies, Clinical and Experimental Rheumatology, 7, 499 Mielants, 1990, HLA-B27 positive idiopathic acute anterior uveitis: a unique manifestation of subclinical gut inflammation, Journal of Rheumatology, 17, 841 Mielants, 1991, Gut inflammation in the spondylarthropathies: clinical, radiological, biologic and genetic features in relation to the type of histology. A prospective study, Journal of Rheumatology, 18, 1542 Mielants, 1991, Intestinal permeability in inflammatory rheumatic diseases. II. Role of disease, Journal of Rheumatology, 18, 394 Mielants, 1993, Gut inflammation in children with late onset pauciarticular juvenile chronic arthritis and evolution to adult spondylarthropathy—a prospective study, Journal of Rheumatology, 20, 1567 Mielants, 1993, A prospective study of patients with spondylarthropathy with special reference to HLA-B27 and to gut histology, Journal of Rheumatology, 20, 1353 Mielants, 1995, The evolution of spondylarthropathies in relation to gut histology. Part I: Prospective study of the clinical spondylarthropathy, Journal of Rheumatology, 22, 2266 Mielants, 1995, The evolution of spondylarthropathies in relation to gut histology. Part II: Role of the presence and type of gut inflammation in the evolution of the spondylarthropathies, Journal of Rheumatology, 22, 2273 Mielants, 1995, The evolution of spondylarthropathies in relation to gut histology. Part III: Prospective study of the clinical evolution of spondylarthropathies in relation to the evolution of gut histology, Journal of Rheumatology, 22, 2279 Mielants, 1995, Influence of Sulphasalazine on the evolution of gut inflammation and locomotor manifestations in the spondylarthropathies, British Journal of Rheumatology, 34, 120 Nissila, 1988, Sulphasalazine in the treatment of ankylosing spondylitis, Arthritis and Rheumatism, 31, 1111, 10.1002/art.1780310905 Peliskova, 1986, Sulphasalazine in reactive arthritis: an open trial, British Journal of Rheumatology, 25, 49 Pullar, 1985, Which component of Sulphasalazine is active in rheumatoid arthritis?, British Journal of Rheumatology, 290, 1535 Schatteman, 1995, Gut inflammation in psoriatic arthritis: a prospective ileocolonoscopic study, Journal of Rheumatology, 22, 680 Simenon, 1990, Macroscopic and microscopic gut lesions in seronegative spondylarthropathies, Journal of Rheumatology, 17, 491 Summers, 1979, National cooperative Crohn's disease study: results of drug treatment, Gastroenterology, 77, 847, 10.1016/0016-5085(79)90385-8 Taurog, 1994, The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats, Journal of Experimental Medicine, 180, 2359, 10.1084/jem.180.6.2359 Taylor, 1991, Sulphasalazine in ankylosing spondylitis and the effects of sulphasalazine over 3 years, Clinical Rheumatology, 32, 729 Trnavsky, 1990, Sulphasalazine in the treatment of reactive arthritis, Scandinavian Journal of Rheumatology, 80, 45 Van Hees, 1981, Effect of Sulphasalazine in patients with active Crohn's disease: a controlled double-blind study, Gut, 22, 404, 10.1136/gut.22.5.404 De Vos, 1989, Ileocolonoscopy in seronegative spondylarthropathy, Gastroenterology, 96, 339, 10.1016/0016-5085(89)91557-6 Wenckert, 1978, The long-term prophylatic effect of salicylazo-sulphapyridine (SalazopyrinR) in primarily resected patients with Crohn's disease, Scandinavian Journal of Rheumatology, 13, 161 Wendling, 1990, Intestinal permeability in ankylosing spondylitis, Journal of Rheumatology, 17, 114 Wright, 1978, Seronegative polyarthritis—A unified concept, Arthritis and Rheumatism, 21, 618, 10.1002/art.1780210603